Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment

Maria Marchante, Ferran Barrachina, Sabrina Piechota, Marta Fernandez-González, Alexa Giovannini, Trozalla Smith, Simone Kats, Bruna Paulsen, Eva González, Virginia Calvente, Ana Silvan, Baruch Abittan, Joshua Klein, Peter Klatsky, Daniel Ordonez, Christian C. Kramme
doi: https://doi.org/10.1101/2024.03.28.24304995

Article usage

Article usage: March 2024 to June 2025

AbstractFullPdf
Mar 2024130021
Apr 20243502662
May 20241041434
Jun 2024351320
Jul 202439825
Aug 202429813
Sep 202422110
Oct 2024211014
Nov 202412210
Dec 20241229
Jan 20252217
Feb 2025163512
Mar 2025223114
Apr 2025462617
May 2025573728
Jun 20253267
Back to top
Posted March 28, 2024.
Download PDF
Data/Code
Email
Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment
Maria Marchante, Ferran Barrachina, Sabrina Piechota, Marta Fernandez-González, Alexa Giovannini, Trozalla Smith, Simone Kats, Bruna Paulsen, Eva González, Virginia Calvente, Ana Silvan, Baruch Abittan, Joshua Klein, Peter Klatsky, Daniel Ordonez, Christian C. Kramme
medRxiv 2024.03.28.24304995; doi: https://doi.org/10.1101/2024.03.28.24304995
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area